Vivimed Labs Board of Directors

Get the latest insights into the leadership at Vivimed Labs. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Manohar Rao VaralwarChairman
Santosh VaralwarManaging Director
Sandeep VaralwarWhole Time Director
Aparna BidarkarNon Executive Independent Director
Subbarathnamma PalepuNon Executive Independent Director
Jarugula Siva PrasadNon Executive Independent Director
Yugandhar KopparthiCompany Secretary & Compliance Officer

Vivimed Labs Share price

VIVIMEDLAB

6.85

0.06 (-0.87%)
NSE
BSE
Last updated on 23 Apr, 2026 | 15:29 IST
Today's High

7.13

Today's Low

6.60

52 Week Low

5.15

52 Week High

29.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vivimed Labs FAQs

The board at Vivimed Labs consists of experienced professionals, including Manohar Rao Varalwar, Santosh Varalwar, and others, overseeing the company’s strategic and corporate governance.

Directors at Vivimed Labs are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Manohar Rao Varalwar is the current chairman at Vivimed Labs.

Executive directors at Vivimed Labs are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vivimed Labs adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vivimed Labs, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost